When the US FDA granted full approval of Biogen (NASDAQ:BIIB) and Eisai's (OTCPK:ESAIY) Alzheimer's treatment Leqembi ...

Alzheimer’s drug Leqembi has full FDA approval THE ASSOCIATED PRESS July 7, 2023 at 07:30 ... WASHINGTON--U.S. officials granted full approval to a closely watched Alzheimer’s drug on ...

The FDA has recently approved exciting new treatments that can slow the progression of Alzheimer’s disease, a scourge that claims more American lives than breast cancer and prostate cancer combined.

Fast-track approval of three risky drugs intends to slow the disease, but evidence they benefit patients is shaky ...

A potential new Alzheimer’s drug represses the harmful inflammatory response of the brain’s immune cells, reducing disease ...

An advisory committee to the U.S. Food and Drug Administration unanimously rejected a drug-and-device combination made by a Boston biotech, which the agency had already rejected twice.

USC researchers played a key role in a new treatment for Alzheimer’s disease, the first with full approval to target a suspected root cause of the condition, offering hope to those with the disease ...

Use one of the services below to sign in to PBS: You've just tried to add this video to My List. But first, we need you to sign in to PBS using one of the services below. You've just tried to add ...

For anyone who has or knows someone who has Alzheimer’s disease, a progressive and irreversible form of dementia that’s ultimately deadly, it can sometimes be difficult to find hope.

The 19-member advisory committee unanimously voted against Intarcia in the review, citing cardiovascular and kidney safety concerns.

While there currently is no cure for Alzheimer’s disease — the most common type of dementia — there are healthy steps a person can take to reduce their risk or possibly prevent it.

A CMS pilot project will test a low-cost way to help families support a suffering loved one. It’s more promising than ...